Hadasit Financial Statements From 2010 to 2024
| HDST Stock | 53.00 0.00 0.00% |
Check Hadasit Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hadasit main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Hadasit financial statements analysis is a perfect complement when working with Hadasit Bio Valuation or Volatility modules.
Hadasit |
Hadasit Bio Company Operating Margin Analysis
Hadasit Bio's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Hadasit Bio Operating Margin | 0.08 % |
Most of Hadasit Bio's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hadasit Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Hadasit Bio has an Operating Margin of 0.0821%. This is 100.23% lower than that of the Biotechnology sector and 100.07% lower than that of the Health Care industry. The operating margin for all Israel stocks is 101.49% lower than that of the firm.
Hadasit Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hadasit Bio's current stock value. Our valuation model uses many indicators to compare Hadasit Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hadasit Bio competition to find correlations between indicators driving Hadasit Bio's intrinsic value. More Info.Hadasit Bio is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Hadasit Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Hadasit Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hadasit Bio's earnings, one of the primary drivers of an investment's value.About Hadasit Bio Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Hadasit Bio income statement, its balance sheet, and the statement of cash flows. Hadasit Bio investors use historical funamental indicators, such as Hadasit Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Hadasit Bio investors may use each financial statement separately, they are all related. The changes in Hadasit Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Hadasit Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Hadasit Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Hadasit Bio. Please read more on our technical analysis and fundamental analysis pages.
Hadasit Bio-Holdings, Ltd operates in the biotechnology industry in Israel. The company was founded in 2005 and is based in Jerusalem, Israel. HBL HADASIT is traded on Tel Aviv Stock Exchange in Israel.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Hadasit Bio Correlation against competitors. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Hadasit Stock analysis
When running Hadasit Bio's price analysis, check to measure Hadasit Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hadasit Bio is operating at the current time. Most of Hadasit Bio's value examination focuses on studying past and present price action to predict the probability of Hadasit Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hadasit Bio's price. Additionally, you may evaluate how the addition of Hadasit Bio to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets |